A family’s experience with integrative cancer treatment at a clinic in Scottsdale, Arizona, has highlighted both the appeal and controversy surrounding alternative therapies for advanced cancer patients. The father, diagnosed with stage 4 lung cancer, sought care outside of conventional medical centers after standard treatments left him exhausted and with limited hope.
Initially hesitant but yearning for more options, the patient and his family explored multiple clinics offering nontraditional, “nontoxic” therapies, including one in Florida and, ultimately, Envita. Envita markets itself as an integrative cancer center combining conventional treatments like chemotherapy, radiation, and immunotherapy with alternative methods, such as vitamin infusions, supplements, and proprietary cell therapies.
The family was drawn by positive anecdotal reports, including from a relative’s acquaintance who described significant improvement after treatment at Envita, as well as the clinic’s location in Arizona, where state regulations allow a broader scope of practice for integrative medicine. Initial consultations involved lengthy discussions and a combined treatment plan costing thousands of dollars per infusion and including travel to a related clinic in Hermosillo, Mexico, for cellular therapies not authorized in the United States.
During the early weeks at Envita, the patient’s symptoms such as shortness of breath and cough appeared to improve, bolstered by supportive care and high doses of steroids that increased his energy. The clinic also provided a social environment where the patient found camaraderie among fellow patients, fostering a sense of hope and community that had been absent in his previous hospital experiences.
However, as treatment progressed, the patient’s condition worsened significantly. He experienced severe weight loss—losing over 40 pounds—as well as increased respiratory distress, bleeding, fatigue, and hair loss. Medical records from the clinic documented these declines, prompting referrals to emergency care and outside specialists, but the primary treatment plan at Envita continued. The family reported that the clinic prescribed a range of supportive therapies, some with limited clinical evidence and known risks, such as hydrogen peroxide infusions, ozone therapy, and coffee enemas.
Despite persistent hope, the patient privately acknowledged the severity of his decline. He experimented with additional unapproved treatments, including fenbendazole, an antiparasitic medication, driven by online testimonials of miraculous recoveries. This decision coincided with a critical drop in his oxygen levels, necessitating emergency hospitalization.
At the hospital, a physician familiar with patients from clinics like Envita expressed skepticism of the treatments, remarking that many arrive in similarly poor condition after pursuing alternative therapies. The family had incurred medical expenses estimated at around $200,000 since relocating to Arizona, covering Envita’s charges and related external therapies.
Envita’s history has been marked by regulatory challenges. Founded in 2001 by Santo Dino Prato, a licensed naturopathic practitioner, the clinic has faced scrutiny from the Food and Drug Administration (FDA). In 2006, the FDA issued a warning for unapproved cell therapy procedures, which later led Envita to operate its cell therapy treatments in Mexico to avoid U.S. regulations. A 2015 FDA report detailed concerns about Envita’s practices, including high costs charged to vulnerable patients and the use of unapproved drugs, as well as complaints lodged by patients and families over the clinic’s experimental approaches and pricing. However, enforcement actions stalled due to a lack of prosecutorial interest.
Additional controversies include a temporary suspension of a doctor’s license linked to negligence in pediatric cancer treatment and a lawsuit alleging that Envita misrepresented the quality of its care. The clinic denied those allegations, and the lawsuit was settled out of court.
The family’s account underscores the complexity of integrative cancer treatments, illustrating both the psychological benefits patients may experience and the risks involved when pursuing therapies outside standard medical protocols. While integrative approaches can offer hope and community, medical experts caution about the lack of robust evidence supporting many alternative treatments and emphasize the importance of informed decision-making in oncology care.